News related to Taxotere (Docetaxel) and/or conditions it is approved for
Positive CHMP Opinion For Xtandi™ (Enzalutamide) In Advanced Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2013.04.30]
Enzalutamide recommended for approval in the European Union (EU) for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy 1 Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc...
|
